Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies

Tissue Engineering - Part A

Volumn 16, Issue 4, 2010, Pages 1143-1155

  Komoda, Hiroshi ^a,b   Okura, Hanayuki ^a,c,d   Lee, Chun Man ^a,e   Sougawa, Nagako ^a   Iwayama, Tomoaki ^f   Hashikawa, Tomoko ^f   Saga, Ayami ^a   Yamamoto Kakuta, Aya ^a   Ichinose, Akihiro ^g   Murakami, Shinya ^f   Sawa, Yoshiki ^c,e   Matsuyama, Akifumi ^a  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^e OSAKA UNIVERSITY HOSPITAL   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDS; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BODY FLUIDS; CELL CULTURE; CELL DEATH; CELL MEMBRANES; FLOATING BREAKWATERS;

ADIPOGENIC; ADIPOSE TISSUE; ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITIES; BONE MARROW; CELL SOURCES; CELL SURFACES; FEEDER CELLS; FETAL BOVINE SERUM; HUMAN ADIPOSE TISSUE; HUMAN EMBRYONIC STEM CELLS; HUMAN MONOCYTE-DERIVED MACROPHAGES; HUMAN SERUM; IMMUNE RESPONSE; N-GLYCOLYLNEURAMINIC ACID; OSTEOGENIC DIFFERENTIATION; PHAGOCYTIC ACTIVITY; PHAGOCYTOSE; REGULATORY PROTEIN; STEM CELL THERAPY;

STEM CELLS;

BOVINAE;

HETEROPHILE ANTIBODY; HETEROPHILE ANTIGEN; N GLYCOLOYLNEURAMINIC ACID; N-GLYCOLYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BONE DEVELOPMENT; CATTLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MACROPHAGE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOUSE; PHAGOCYTOSIS; STROMA CELL; TISSUE ENGINEERING;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; ANTIBODIES, HETEROPHILE; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, HETEROPHILE; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; GRAFT REJECTION; HUMANS; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; NEURAMINIC ACIDS; OSTEOGENESIS; PHAGOCYTOSIS; STROMAL CELLS; TISSUE ENGINEERING;

EID: 77950820582     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0386     Document Type: Article

References (41)

1. Björntorp, P., Karlsson, M., Gustafsson, L., Smith, U., Sjöström, L., Cigolini, M., Storck, G., and Pettersson, P. Quantitation of different cells in the epididymal fat pad of the rat. J Lipid Res 20, 97, 1979.
2. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
3. Okura, H., Matsuyama, A., Lee, C.M., Saga, A., Kakuta- Yamamoto, A., Nagao, A., Sougawa, N., Sekiya, N., Takekita, K., Shudo, Y., Miyagawa, S., Komoda, H., Okano, T., and Sawa, Y. Cardiomyoblast-like cells differentiated from human adipose tissue-derived mesenchymal stem cells improve left ventricular dysfunction and survival in a rat myocardial infarction model. Tissue Eng Part C Methods July 22, 2009. [Epub ahead of print].
4. Okura, H., Fumimoto, Y., Komoda, H., Yanagisawa, T., Nishida, T., Noguchi, S., Sawa, Y., and Matsuyam, A. Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif Organs 12, 123, 2009.
5. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
6. Kern, S., Eichler, H., Stoeve, J., Klüter, H., Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294, 2006.
7. Romanov, Y.A., Darevskaya, A.N., Merzlikina, N.V., and Buravkova, L.B. Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities. Bull Exp Biol Med 140, 138, 2005.
8. Sotiropoulou, P.A., Perez, S.A., Salagianni, M., Baxevanis, C.N., and Papamichail, M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24, 462, 2006.
9. Mazzini, L., Fagioli, F., Boccaletti, R., Mareschi, K., Oliveri, G., Olivieri, C., Pastore, I., Marasso, R., and Madon, E. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 4, 158, 2003.
10. Bang, O.Y., Lee, J.S., Lee, P.H., and Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57, 874, 2005.
11. Chen, S.L., Fang, W.W., Ye, F., Liu, Y.H., Qian, J., Shan, S.J., Zhang, J.J., Chunhua, R.Z., Liao, L.M., Lin, S., and Sun, J.P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94, 92, 2004.
12. Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., and Hofmann, T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99, 8932, 2002.
13. Martin, M.J., Muotri, A., Gage, F., and Varki, A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11, 228, 2005.
14. Heiskanen, A., Satomaa, T., Tiitinen, S., Laitinen, A., Mannelin, S., Impola, U., Mikkola, M., Olsson, C., Miller- Podraza, H., Blomqvist, M., Olonen, A., Salo, H., Lehenkari, P., Tuuri, T., Otonkoski, T., Natunen, J., Saarinen, J., and Laine, J. N-Glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197, 2007.
15. Nowak, J.A., Jain, N.K., Stinson, M.W., and Merrick, J.M. Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human Hanganutziu-Deicher serum. Mol Immunol 23, 693, 1986.
16. Chou, H.H., Takematsu, H., Diaz, S., Iber, J., Nickerson, E., Wright, K.L., Muchmore, E.A., Nelson, D.L., Warren, S.T., and Varki, A. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 95, 11751, 1998.
17. Hayakawa, T., Satta, Y., Gagneux, P., Varki, A., and Takahata, N. Alu-mediated inactivation of the human CMP-Nacetylneuraminic acid hydroxylase gene. Proc Natl Acad Sci USA 98, 11399, 2001.
18. Bardor, M., Nguyen, D.H., Diaz, S., and Varki, A. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem 280, 4228, 2005.
19. Lanctot, P.M., Gage, F.H., and Varki, A.P. The glycans of stem cells. Curr Opin Chem Biol 11, 373, 2007.
20. Zhu, A., and Hurst, R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 9, 376, 2002.
21. Nguyen, D.H., Tangvoranuntakul, P., and Varki, A. Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. J Immunol 175, 228, 2005.
22. Tangvoranuntakul, P., Gagneux, P., Diaz, S., Bardor, M., Varki, N., Varki, A., and Muchmore, E. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci USA 100, 12045, 2003.
23. Cerdan, C., Bendall, S.C., Wang, L., Stewart, M., Werbowetski, T., and Bhatia, M. Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. Nat Med 12, 1113, 2006.
24. Asaoka, H., Nishinaka, S., Wakamiya, N., Matsuda, H., and Murata, M. Two chicken monoclonal antibodies specific for heterophil Hanganutziu-Deicher antigens. Immunol Lett 32, 91, 1992.
25. Matsuyama, A., Yamashita, S., Sakai, N., Maruyama, T., Okuda, E., Hirano, K., Kihara, S., Hiraoka, H., and Matsuzawa, Y. Identification of a GPI-anchored type HDL-binding protein on human macrophages. Biochem Biophys Res Commun 272, 864, 2000.
26. Hashikawa, T., Takedachi, M., Terakura, M., Yamada, S., Thompson, L.F., Shimabukuro, Y., and Murakami, S. Activation of adenosine receptor on gingival fibroblasts. J Dent Res 85, 739, 2006.
27. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102, 344, 1980.
28. Schaapherder, A.F., Daha, M.R., te Bulte, M.T., van der Woude, F.J., and Gooszen, H.G. Antibody-dependent cellmediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 57, 1376, 1994.
29. Ezzelarab, M., Ayares, D., and Cooper, D.K. Carbohydrates in xenotransplantation. Immunol Cell Biol 83, 396, 2005.
30. Yang, Y.G., and Sykes, M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 7, 519, 2007.
31. Roos, A., and Daha, M.R. Antibody-mediated activation of the classical complement pathway in xenograft rejection. Transpl Immunol 9, 257, 2002.
32. Miyagawa, S., Kubo, T., Matsunami, K., Kusama, T., Beppu, K., Nozaki, H., Moritan, T., Ahn, C., Kim, J.Y., Fukuta, D., and Shirakura, R. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complementmediated cytolysis but not NK cell-mediated cytolysis. J Immunol 173, 3945, 2004.
33. Komoda, H., Miyagawa, S., Kubo, T., Kitano, E., Kitamura, H., Omori, T., Ito, T., Matsuda, H., and Shirakura, R. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 11, 237, 2004.
34. Diamond, L.E., Quinn, C.M., Martin, M.J., Lawson, J., Platt, J.L., and Logan, J.S. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 71, 132, 2001.
35. Schuurman, H.J., Pino-Chavez, G., Phillips, M.J., Thomas, L., White, D.J., and Cozzi, E. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAFtransgenic donors. Transplantation 73, 1146, 2002.
36. Zhou, C.Y., McInnes, E., Copeman, L., Langford, G., Parsons, N., Lancaster, R., Richards, A., Carrington, C., and Thompson, S. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor. Xenotransplantation 12, 142, 2005.
37. Chen, G., Qian, H., Starzl, T., Sun, H., Garcia, B., Wang, X., Wise, Y., Liu, Y., Xiang, Y., Copeman, L., Liu, W., Jevnikar, A., Wall, W., Cooper, D.K., Murase, N., Dai, Y., Wang, W., Xiong, Y., White, D.J., and Zhong, R. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 11, 1295, 2005.
38. Chen, G., Sun, H., Yang, H., Kubelik, D., Garcia, B., Luo, Y., Xiang, Y., Qian, A., Copeman, L., Liu, W., Cardella, C.J., Wang, W., Xiong, Y., Wall, W., White, D.J., and Zhong, R. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation 81, 273, 2006.
39. Saethre, M., Baumann, B.C., Fung, M., Seebach, J.D., and Mollnes, T.E. Characterization of natural human anti-nongal antibodies and their effect on activation of porcine galdeficient endothelial cells. Transplantation 84, 244, 2007.
40. Ide, K., Ohdan, H., Kobayashi, T., Hara, H., Ishiyama, K., and Asahara, T. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation 12, 181, 2005.
41. Yamaguchi, M., Hirayama, F., Wakamoto, S., Fujihara, M., Murahashi, H., Sato, N., Ikebuchi, K., Sawada, K., Koike, T., Kuwabara, M., Azuma, H., and Ikeda, H. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion 42, 921, 2002.